The 2nd Annual World Conference On Genitourinary Cancers will bring together over 60 esteemed faculty members that span the multidisciplinary spectrum, including leading national experts, community oncologists, and urologists. This comprehensive two-day CME/CE event is specifically designed to equip healthcare professionals with the insights needed to navigate the increasingly complex landscape of genitourinary cancer diagnosis and treatment.
Sessions across the primary disease areas of bladder cancer, prostate cancer, and renal cell carcinoma will analyze current therapeutic standards for care with experts who have helped shape the field and explore divergent perspectives surrounding the latest treatment strategies. Attendees will also gain exposure to recent developments in disease monitoring, including the use of biomarkers and novel imaging approaches to guide treatment decisions. Experts will discuss and debate the way the explosive treatment landscape is driven by these rapid therapeutic and technological advancements, and consider the way they are revolutionizing GU cancer treatment approaches. Special sessions will focus on less common tumors as well as emerging drug classes and diagnostic tools.
The conference aims to empower attendees with the latest knowledge to improve patient outcomes in GU cancer treatment. Our renowned faculty, from both academic and community practices, will engage in thoughtful debates on various treatment approaches and clinical applications. Open panel discussions and ample opportunities for live Q&A sessions will foster interaction and learning. This CME/CE conference offers a unique opportunity to stay at the forefront of GU cancer care and equip attendees with the skills to navigate the complexities of modern treatment.
#WorldGU25
Upon completion, learners will be able to:
Describe the factors that impact Precision Medicine applications within the genitourinary cancer context
Analyze the progressive integration and significance of multidisciplinary care in managing genitourinary cancers
Identify the challenges and opportunities inherent in sequential therapies for genitourinary cancers
The target audience for World GU 2025 is healthcare professionals who treat patients with genitourinary cancers. Medical oncologists, fellows, advanced practice providers, surgeons, urologists, radiation oncologists and other healthcare professionals with an interest in GU cancers are invited to attend.
The Conference Venue
Nestled in the heart of Music City, the state-of-the-art, 776-seat CMA Theater is a unique—and sought after—Nashville venue for live events. The CMA Theater was built with its audience in mind, to ensure that each seat feels like a “front-row” experience, providing a rich learning environment.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Mauris duis commodo vitae orci litora. Phasellus pede aliquam placerat commodo felis ornare. Lacus laoreet porttitor ante montes eros.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
888-2003-212
support@domain.tld
© 2025 IDEOlogy Health. All product names, logos, brands, trademarks and registered trademarks are property of their respective owners and their use(s) do not necessarily imply endorsement.